Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2

Disappointing when just looking at the Quarter's revenue, but DVL's revenue stream can't be broken down into quarterly figures due to the nature of the business:

More important is this bit:

Advanced critical data and technology security clearance for major US clinical franchise
dorsaVi continues to progress toward finalising critical data and technology security clearance with a
leading US clinical franchise group, following a 12-month pilot development project.
To support this, dorsaVi is making targeted investments to meet the group’s strict data and security
requirements, leveraging its existing FDA Clearance and ISO27001 security certification. Successful
clearance could enable broader adoption of dorsaVi’s solutions across a network of several thousand
physical therapy centres, significantly expanding dorsaVi’s commercial footprint.


This gem is still in its infancy stage, but could mature very quickly. Sp reflects the uncertainty and risk which is warranted at this stage. Pure speculation atm but could turn into a serious investment.

GLTA